Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.

MLA

Singh, Siddharth, et al. “Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 18, no. 1, Jan. 2020, p. 69. EBSCOhost, https://doi.org/10.1016/j.cgh.2019.02.044.

APA

Singh, S., Facciorusso, A., Dulai, P. S., Jairath, V., & Sandborn, W. J. (2020). Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 18(1), 69. https://doi.org/10.1016/j.cgh.2019.02.044

Chicago

Singh, Siddharth, Antonio Facciorusso, Parambir S Dulai, Vipul Jairath, and William J Sandborn. 2020. “Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 18 (1): 69. doi:10.1016/j.cgh.2019.02.044.